Valensa International, Orlando, FL, has received a series of patents covering the composition and application of nutraceutical formulations featuring Perilla seed oil as a major component. The most important of these new patents is one that covers the use of Perilla seed oil alone or in combination with other omega-3 sources such as krill oil, algae oils, fish oils and other seed oils for cardiovascular health support.
 
Recent research points to the importance of a lowered omega-6/omega-3 ratio and its impact on chronic inflammation in the body as a major contributor to better cardiovascular health. Numerous studies have shown that a high omega-6/omega-3 ratio increases the risk of heart attacks and stroke by as much as 30%. With an omega-3 to omega-6 ratio of 6:1 — the highest naturally occurring seed-based ratio in nature — Perilla seed oil is an ideal way to address the omega-6/omega-3 imbalance which is common to Western diets, said the company.
 
Valensa markets a range of supercritical CO2 extract Perilla-based formulations including Verilla Perilla Seed Extract, Kerilla Perilla Seed Extract + Krill Oil, VerillaMax Perilla Seed Flour, Zanthin Xp-3 Perilla seed extract with astaxanthin and Z-Omega 3-6-9 — a combination of chia seed extract, Perilla seed extract and olive extract. The company plans to utilize this new intellectual property in a range of new formulated products.
 
According to Dr. Rudi E. Moerck, President & CEO of Valensa, new research on the vegan and vegetarian communities is starting to bring the role of different types of omega-3 fatty acids the cardiovascular health into better focus. “Recent research has shown us that cardiovascular mortality rates for vegans and vegetarians are higher than those who consume a Western-type meat-based diet — despite the positive impact that vegan/vegetarian diets have on important CVD markers. Even newer research points us to why this may be the case. Vegetarians —and even more so vegans — have a very high omega-6 to omega-3 fatty acid ratio in their systems — up to 15 to 17:1 and science tells us that this number needs to be closer to 4:1. These high ratios stimulate the production of arachidonic acid (AA) which greatly increases inflammation in the body, which cam lead  to a number of different chronic health conditions — particularly cardiovascular disease and strokes,” he said. “Perilla seed oil is a remarkable natural substance because of its omega-3/omega-6 composition of 6:1 its containing up to 60% alphalinolenic acid (ALA). We’re excited about the opportunity to develop a range of new Perilla-based formulations for cardiovascular support – particularly as we begin to refine our understanding of the benefits of different marine and algae-based Omega-3s in supplying EPA/DHA and how they can work together with Perilla to create revolutionary formulations for cardiovascular support,” he said.